Elizabeth Hossan
-
- Cancer Treatment and Pharmacology 2
- Vascular Tumors and Angiosarcomas 1
-
- Bladder and Urothelial Cancer Treatments 8
- Urinary and Genital Oncology Studies 5
-
- Urological Disorders and Treatments 2
-
- Prostate Cancer Treatment and Research 4
-
- Cancer Research and Treatments 4
-
- Virus-based gene therapy research 2
- Co-authors
- Christopher J. LogothetisRobert G. KilbournF. H. DexeusRobert J. AmatoShi‐Ming TuFrancisco H. DexeusMelvin L. SamuelsR. J. Amato
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Clinical Cancer Research (1 paper)The Journal of Urology (5 papers)
- Partner nations
- United StatesSpain
In The Last Decade
Elizabeth Hossan
12 papers receiving 320 citations
Peers
Comparison fields: 5 of 41
- Oncology 132
- Surgery 159
- Urology 21
- Pulmonary and Respiratory Medicine 106
- Cancer Research 35
Countries citing papers authored by Elizabeth Hossan
This map shows the geographic impact of Elizabeth Hossan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Hossan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Hossan more than expected).
Fields of papers citing papers by Elizabeth Hossan
This network shows the impact of papers produced by Elizabeth Hossan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Hossan. The network helps show where Elizabeth Hossan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Hossan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 38 | |
| 2 | 1999 | 4 | |
| 3 | 1999 | 9 | |
| 4 | 1995 | 6 | |
| 5 | 1995 | 74 | |
| 6 | SMS 201-995 in the treatment of refractory prostatic carcinoma. | 1994 | 33 |
| 7 | 5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen. | 1994 | 13 |
| 8 | 1993 | 2 | |
| 9 | 1991 | 52 | |
| 10 | 1987 | 12 | |
| 11 | 1986 | 48 | |
| 12 | Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer. | 1985 | 40 |
About Elizabeth Hossan
Elizabeth Hossan is a scholar working on Biotechnology, Urology and Surgery, having authored 12 papers that have together received 331 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Urinary and Genital Oncology Studies (5 papers), Cancer Research and Treatments (4 papers), Prostate Cancer Treatment and Research (4 papers), Virus-based gene therapy research (2 papers), Urological Disorders and Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Oncology (132 citations), Surgery (159 citations) and Urology (21 citations). Elizabeth Hossan has collaborated with scholars based in United States and Spain. Frequent co-authors include Christopher J. Logothetis, Robert G. Kilbourn, F. H. Dexeus, Robert J. Amato, Shi‐Ming Tu, Francisco H. Dexeus, Melvin L. Samuels, R. J. Amato, Avishay Sella and Terry L. Smith. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Clinical Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.